CMED and Tessella team up on trials

- Last updated on GMT

Related tags: The trial

CRO CMED and IT group Tessella are teaming up to offer adaptive trial data management and acquisition services to the drug industry.

The collaboration will focus on development of an approach that combines CMED’s Timaeus data management platform with Tessella’s existing Fates adaptive trial execution system.

Tom Parke, head of clinical technologies at Tessella, said: “With Timaeus, organisations have the ability to acquire, manage and report data in near real-time. This is particularly important for adaptive trials because it minimises the delay in the availability of response data and therefore adaptation of the trial​.”

Richard Young, Director of Business Development at CMED said: “Tessella and Cmed have been collaborating for some time… entering into a partnership this will reinforce our capabilities, and provide unparalleled solutions for adaptive designs.”

Related news

Show more

Related products

show more

What should a clinical metadata repository do?

What should a clinical metadata repository do?

Formedix | 26-Jul-2021 | Technical / White Paper

Choosing a clinical metadata repository (MDR) software can be a tough task as the capabilities and features of your chosen MDR could make or break your...

Adapting supply chains to new ways of working

Adapting supply chains to new ways of working

World Courier | 15-Jul-2021 | Technical / White Paper

COVID-19 has changed the way we operate. We have adapted our supply chain solutions to meet our clients’ requirements while following World Courier standard...

Related suppliers

Follow us

Products

View more

Webinars